Establishment of guideline concerning residual solvent criteria of drugs eyed
Published: 2003-01-15 06:57:00
Updated: 2003-01-15 06:57:00
The Food and Drug Administration (KFDA) announced it has drafted a new guideline concerning the residual solvent criteria of drugs that sets out the types of solvent, its restricted concentration and analytical methods used for the manufacture of drugs.
The KFDA further noted that this guide ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
